Bottom Line: What to Know Before Starting With altRx altRx is a self-pay GLP-1 telehealth platform that, according to its own published source materials, operates a clearly disclosed three-entity model: altRx as the technology and marketing platform, independent medical groups as the clinical decision-makers, and partner pharmacies described by altRx as USA-certified as the medication dispensers
Eric Topol, in a July 2025 review of the evidence on peptide therapies, grouped ipamorelin with CJC-1295 and tesamorelin as growth-hormone-related peptides that "carry the potential risk of cancer" on mechanistic grounds, because sustained IGF-1 elevation promotes cell proliferation broadly [4]
The overall level of evidence for the articles assessed is low and much of the practice management recommendations are only based on expert opinion
They can help you determine if this approach is right for you and how to do it safely
however, it has a significant role in fat metabolism and energy formation, which is indirectly associated with better physical performance and weight management
Real Dr